ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 684836 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 684836; 2) Community: the network communities that were significantly associated with the response to NSC 684836; 3) Molecule: the relationships between components within communities and NSC 684836; 4) MDR: the compounds that were significantly associated with the NSC 684836.

NSC Compound Enrichment Correlation
NSC 104801 Cytembena 0.0208632511155816 0.22583735
NSC 107043 Null 0.0208632511155816 0.43046444
NSC 114340 Ophiobolin A 0.0208632511155816 0.20649191
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0208632511155816 0.098392994
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0208632511155816 0.17451375
NSC 208885 Null 0.0208632511155816 0.067571372
NSC 28608 Null 0.0208632511155816 0.44828146
NSC 287069 Epicorazine A 0.0208632511155816 0.31746945
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.0208632511155816 0.2102168
NSC 330507 Tanespimycin 0.0208632511155816 0.17985261
Total:118  Current:54    [First] [Prev] [Next] [Last]